Product details

On March 23, 2021, Vineet Sharma, the sole owner of MedStar Polymers, India, a medical-grade latex glove manufacturing company, was considering the dilemma of how to scale up production to fulfill an unprecedented order during COVID-19. With demand for protective equipment outstripping global supply during the pandemic, an exceptional business growth and expansion opportunity for glove manufacturers had emerged. Several manufacturers had expanded production by adding new production lines. On the surface, a production ramp-up looked as simple as increasing inputs: raw material, labour, machinery, equipment, and cash. However, a decision to rapidly increase production could create risk and almost destroy a business-especially when constraints such as raw material unavailability, transport and travel restrictions, logistical problems, and state- and area-wide lockdowns started impacting the production process. Sharma had to decide how to increase output while also dealing with disruptions such as a shortage of labour and concerns about the use of natural latex rubber. Was now the right time to add a new production line? Should he switch to making nitrile gloves? He needed to make decisions quickly, as the current high demand would likely not last.